Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer
Clinical trial NCT03634150 · WITHDRAWN
Trial details
- NCT number
- NCT03634150
- Sponsor
- Immune System Key Ltd
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-06
- Primary completion
- 2020-04-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.